Project Details
| Status | Active |
|---|---|
| Effective start/end date | 4/20/21 → 4/20/26 |
Funding
- Memorial Sloan-Kettering Cancer Center (Prot #NU MSK20C04 // Prot #NU MSK20C04)
- Novocure GmbH (Prot #NU MSK20C04 // Prot #NU MSK20C04)
Prot #NU MSK20C04: The PROTECT Study: A Phase II, Open-Label Trial of PROphylactic Skin Toxicity ThErapy with Clindamycin and Triamcinolone in Glioblastoma Patients Treated with Tumor Treating Fields
- Kumthekar, Priya U (PD/PI)
Project: Research project